COP1 regulates the expression of endogenous PEPCK and G6Pase gene.
A, real time PCR analysis of endogenous G6Pase and PEPCK genes
expression. Fao cells were infected with GFP (CTL) or COP1- or
COP1-shRNA (shRNA)-expressing adenoviruses. 30 h post-infection the
cells were serum-starved overnight followed by 4 h of treatment with either
DMSO, 0.5 μm dexamethasone, 2.5 μm forskolin
(D/F), or 0.5 μm dexamethasone, 0.5 μm
forskolin, 100 nm insulin (In). RNA was prepared for real
time-RT-PCR to detect G6Pase gene expression. B, same as A,
except that here we assessed expression of PEPCK. C, chromatin
immunoprecipitation assay to show FoxO1 binding to G6Pase promoter. Fao cells
in 15-cm dishes were processed as in A except for the chromatin
immunoprecipitation assay. The presence of the G6Pase promoter (panel
i) in the chromatin immunoprecipitate of anti-FoxO1 and in the chromatin
preparation before immunoprecipitation (input, panel ii)) was then
assayed using PCR as described under “Experimental Procedures.” In
addition, a portion of cells were used to prepare the total cell lysates for
Western blotting with anti-FoxO1 (panel iii), anti-COP1 (panel
iv), anti-Akt (panel v), and anti-p110γ (panel
vi) antibodies. D, glucose output assay. The same cells as in
A were serum-deprived overnight, and the medium was replaced with
glucose-free, phenol-free medium. After 4 h of treatment with the indicated
reagents, the medium was collected and subjected to glucose assay with Sigma
glucose assay reagents, and d-glucose served as a standard for the
assay. The experiments were carried out in triplicate, and the amount of
glucose in the medium was normalized to levels of total cellular protein. In
all the experiments, each bar represents the mean ± S.D.
(n = 3). The p values were related to the control
conditions. *, p < 0.015; **, p < 0.005; #, p
< 0.011.